Petmed Express Stock Performance
| PETS Stock | USD 3.62 0.14 4.02% |
The company holds a Beta of 0.97, which implies possible diversification benefits within a given portfolio. PetMed Express returns are very sensitive to returns on the market. As the market goes up or down, PetMed Express is expected to follow. At this point, PetMed Express has a negative expected return of -0.4%. Please make sure to check PetMed Express' value at risk, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if PetMed Express performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days PetMed Express has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in June 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 4.02 | Five Day Return 3.43 | Year To Date Return (21.98) | Ten Year Return (77.85) | All Time Return (56.78) |
Last Split Factor 959692:319 | Dividend Date 2023-08-18 | Ex Dividend Date 2023-08-11 | Last Split Date 1999-03-04 |
1 | PetMed Express Q3 Earnings Preview | 02/10/2025 |
2 | Q3 2025 Petmed Express Inc Earnings Call Transcript | 02/11/2025 |
3 | Earnings call transcript PetMed Express Q4 2024 sees stock drop after earnings miss - MSN | 02/14/2025 |
4 | Acquisition by Nina Capital Holdings Inc. of 50000 shares of PetMed Express at 4.325 subject to Rule 16b-3 | 03/03/2025 |
5 | Disposition of tradable shares by Purcel Diana G of PetMed Express subject to Rule 16b-3 | 03/05/2025 |
6 | Bear of the Day PetMed Express - Nasdaq | 03/07/2025 |
7 | Acquisition by Nina Capital Holdings Inc. of 100000 shares of PetMed Express at 4.11 subject to Rule 16b-3 | 03/10/2025 |
8 | Major Investment Alert Petmed Express Sees Significant Shareholder Activity - TipRanks | 03/11/2025 |
9 | Acquisition by Nina Capital Holdings Inc. of 100000 shares of PetMed Express at 4.085 subject to Rule 16b-3 | 03/18/2025 |
10 | Petmed Express sees 408,500 stock purchase by Nina Capital Holdings - Investing.com | 03/19/2025 |
11 | Acquisition by Mennen Justin L. of 7500 shares of PetMed Express subject to Rule 16b-3 | 04/04/2025 |
12 | Some Confidence Is Lacking In PetMed Express, Inc. As Shares Slide 26 | 04/09/2025 |
13 | PetMed Express Rating Increased to Buy at StockNews.com | 04/16/2025 |
14 | Disposition of 1565 shares by Sandra Campos of PetMed Express at 3.3319 subject to Rule 16b-3 | 04/30/2025 |
15 | PetMed Express, Inc. Shares Sold by Two Sigma Securities LLC | 05/02/2025 |
| Begin Period Cash Flow | 104.1 M | |
| Free Cash Flow | -194 K |
PetMed Express Relative Risk vs. Return Landscape
If you would invest 491.00 in PetMed Express on February 4, 2025 and sell it today you would lose (129.00) from holding PetMed Express or give up 26.27% of portfolio value over 90 days. PetMed Express is currently does not generate positive expected returns and assumes 4.1098% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than PetMed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PetMed Express Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PetMed Express' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PetMed Express, and traders can use it to determine the average amount a PetMed Express' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0968
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PETS |
Estimated Market Risk
| 4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PetMed Express is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PetMed Express by adding PetMed Express to a well-diversified portfolio.
PetMed Express Fundamentals Growth
PetMed Stock prices reflect investors' perceptions of the future prospects and financial health of PetMed Express, and PetMed Express fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PetMed Stock performance.
| Return On Equity | 0.0036 | |||
| Return On Asset | 0.0093 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 25.68 M | |||
| Shares Outstanding | 20.66 M | |||
| Price To Earning | 12.75 X | |||
| Price To Book | 0.72 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 281.06 M | |||
| Gross Profit | 68.37 M | |||
| EBITDA | (1.11 M) | |||
| Net Income | (7.46 M) | |||
| Cash And Equivalents | 105.41 M | |||
| Cash Per Share | 5.21 X | |||
| Total Debt | 1.45 M | |||
| Current Ratio | 5.61 X | |||
| Book Value Per Share | 4.66 X | |||
| Cash Flow From Operations | 4.32 M | |||
| Earnings Per Share | 0.01 X | |||
| Market Capitalization | 74.78 M | |||
| Total Asset | 169.88 M | |||
| Retained Earnings | 71.56 M | |||
| Working Capital | 21.49 M | |||
| Current Asset | 67.63 M | |||
| Current Liabilities | 7.08 M | |||
About PetMed Express Performance
Assessing PetMed Express' fundamental ratios provides investors with valuable insights into PetMed Express' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the PetMed Express is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 59.22 | 63.34 | |
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.08) | (0.07) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about PetMed Express performance evaluation
Checking the ongoing alerts about PetMed Express for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PetMed Express help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PetMed Express generated a negative expected return over the last 90 days | |
| PetMed Express has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 281.06 M. Net Loss for the year was (7.46 M) with profit before overhead, payroll, taxes, and interest of 68.37 M. | |
| PetMed Express has a strong financial position based on the latest SEC filings | |
| About 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: PetMed Express, Inc. Shares Sold by Two Sigma Securities LLC |
- Analyzing PetMed Express' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PetMed Express' stock is overvalued or undervalued compared to its peers.
- Examining PetMed Express' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PetMed Express' management team can have a significant impact on its success or failure. Reviewing the track record and experience of PetMed Express' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PetMed Express' stock. These opinions can provide insight into PetMed Express' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.